Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 251
Filter
1.
J Pathol Clin Res ; 10(1): e352, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38117182

ABSTRACT

Tuft cells are chemosensory cells associated with luminal homeostasis, immune response, and tumorigenesis in the gastrointestinal tract. We aimed to elucidate alterations in tuft cell populations during gastric atrophy and tumorigenesis in humans with correlative comparison to relevant mouse models. Tuft cell distribution was determined in human stomachs from organ donors and in gastric pathologies including Ménétrier's disease, Helicobacter pylori gastritis, intestinal metaplasia (IM), and gastric tumors. Tuft cell populations were examined in Lrig1-KrasG12D , Mist1-KrasG12D , and MT-TGFα mice. Tuft cells were evenly distributed throughout the entire normal human stomach, primarily concentrated in the isthmal region in the fundus. Ménétrier's disease stomach showed increased tuft cells. Similarly, Lrig1-Kras mice and mice overexpressing TGFα showed marked foveolar hyperplasia and expanded tuft cell populations. Human stomach with IM or dysplasia also showed increased tuft cell numbers. Similarly, Mist1-Kras mice had increased numbers of tuft cells during metaplasia and dysplasia development. In human gastric cancers, tuft cells were rarely observed, but showed positive associations with well-differentiated lesions. In mouse gastric cancer xenografts, tuft cells were restricted to dysplastic well-differentiated mucinous cysts and were lost in less differentiated cancers. Taken together, tuft cell populations increased in atrophic human gastric pathologies, metaplasia, and dysplasia, but were decreased in gastric cancers. Similar findings were observed in mouse models, suggesting that, while tuft cells are associated with precancerous pathologies, their loss is most associated with the progression to invasive cancer.


Subject(s)
Gastritis, Hypertrophic , Stomach Neoplasms , Humans , Mice , Animals , Hyperplasia/pathology , Gastric Mucosa/pathology , Gastritis, Hypertrophic/pathology , Stomach Neoplasms/pathology , Proto-Oncogene Proteins p21(ras) , Tuft Cells , Transforming Growth Factor alpha , Carcinogenesis , Metaplasia/pathology
3.
BMJ Case Rep ; 12(10)2019 Oct 23.
Article in English | MEDLINE | ID: mdl-31645399

ABSTRACT

Menetrier disease is a rare disease characterised by hyperplasia of the gastric epithelium and large gastric folds. We present a case of a 58-year-old woman who was referred with iron deficiency anaemia, with a family history of a sibling who had undergone gastrectomy for presumed gastric malignancy. Endoscopy showed prominent gastric mucosal folds and biopsies showed hyperplastic gastric mucosa, with prominent foveolar hyperplasia suggestive of Menetrier disease. Further information about her brother's diagnosis was sought, and it was found that his pathology after gastrectomy showed diffuse glandular hyperplasia also in keeping with Menetrier disease. Adult familial Menetrier disease has so far been a rarity in the literature-review elicits five previous cases of this presentation in siblings.


Subject(s)
Gastric Mucosa/pathology , Gastritis, Hypertrophic/diagnosis , Gastritis, Hypertrophic/genetics , Siblings , Endoscopy, Gastrointestinal , Female , Gastritis, Hypertrophic/pathology , Humans , Hyperplasia/pathology , Male , Middle Aged , Rare Diseases
4.
Intern Med ; 58(13): 1877-1883, 2019 Jul 01.
Article in English | MEDLINE | ID: mdl-30918187

ABSTRACT

A 60-year-old man was referred for the investigation of giant gastric folds, life-threatening anemia and hypoproteinemia. A combination of multiple endoscopic procedures derived a clinical diagnosis of protein-losing gastropathy with two gastric adenomas. After two months of alimentary therapy, the patient received total gastrectomy and fully recovered. The final pathological diagnosis was hypertrophic gastropathy of unknown origin with concomitant adenocarcinoma arising from a gastric type adenoma.


Subject(s)
Adenocarcinoma/pathology , Adenocarcinoma/surgery , Adenoma/complications , Gastric Mucosa/pathology , Gastritis, Hypertrophic/pathology , Gastritis, Hypertrophic/surgery , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery , Adenocarcinoma/etiology , Gastrectomy/methods , Gastritis, Hypertrophic/etiology , Humans , Male , Middle Aged , Stomach Neoplasms/etiology , Treatment Outcome
6.
Rev. méd. Chile ; 147(1): 119-124, 2019. graf
Article in Spanish | LILACS | ID: biblio-991382

ABSTRACT

IgG4 related disease is a systemic autoimmune disease, which can affect different organs. The most common digestive manifestation is autoimmune pancreatitis (AIP), followed by involvement of bile ducts and the major papilla. The stomach is only rarely involved. We report a 71-year-old diabetic woman consulting for jaundice and weight loss. Abdominal CAT scan, cholangio resonance imaging, endosonography and a serum IgG4 of five times the normal value, lead to the diagnosis of an autoimmune pancreatitis. An upper gastrointestinal endoscopy showed a diffuse thickening of gastric folds. The pathological study confirmed the presence of IgG4 positive plasma cells. The patient was successfully treated with steroids.


Subject(s)
Humans , Female , Aged , Immunoglobulin G4-Related Disease/pathology , Gastritis, Hypertrophic/pathology , Pancreatitis/pathology , Biopsy , Immunohistochemistry , Tomography, X-Ray Computed/methods , Gastroscopy/methods , Immunoglobulin G4-Related Disease/diagnostic imaging , Gastric Mucosa/pathology , Gastritis, Hypertrophic/diagnostic imaging
7.
Rev Assoc Med Bras (1992) ; 63(3): 215-218, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28489125

ABSTRACT

Ménétrier's disease is an extremely rare disease of unknown etiology causing gastric mucosal hypertrophy and protein-losing gastropathy. Rare cases of this condition have been reported in patients with autoimmune diseases. However, to the best of our knowledge, Ménétrier's disease associated with autoimmune pancreatitis (AIP) has never been reported. We described a case of severe hypoproteinemia as a harbinger of Ménétrier's disease associated with AIP. The patient was successfully treated with octreotide and high-protein diet, which led to symptomatic remission and significant improvement in serum levels of albumin and recovery of the nutritional status. Thus, in AIP patients presenting with severe and persistent hypoproteinemia without apparent cause, clinicians need to consider Ménétrier's disease in the differential diagnosis. In this setting, endoscopic evaluation with histological examination of gastric biopsy material, including a full-thickness mucosal biopsy of involved mucosa, may be helpful in promptly establishing the diagnosis and allowing appropriate and timely therapy.


Subject(s)
Autoimmune Diseases/complications , Gastritis, Hypertrophic/complications , Hypoproteinemia/etiology , Pancreatitis/complications , Autoimmune Diseases/blood , Autoimmune Diseases/pathology , Biopsy , Endoscopy, Gastrointestinal , Gastric Mucosa/pathology , Gastritis, Hypertrophic/blood , Gastritis, Hypertrophic/pathology , Humans , Hypoproteinemia/pathology , Male , Middle Aged , Pancreatitis/blood , Pancreatitis/pathology , Severity of Illness Index
8.
Rev. Assoc. Med. Bras. (1992) ; 63(3): 215-218, Mar. 2017. graf
Article in English | LILACS | ID: biblio-956439

ABSTRACT

Summary Ménétrier's disease is an extremely rare disease of unknown etiology causing gastric mucosal hypertrophy and protein-losing gastropathy. Rare cases of this condition have been reported in patients with autoimmune diseases. However, to the best of our knowledge, Ménétrier's disease associated with autoimmune pancreatitis (AIP) has never been reported. We described a case of severe hypoproteinemia as a harbinger of Ménétrier's disease associated with AIP. The patient was successfully treated with octreotide and high-protein diet, which led to symptomatic remission and significant improvement in serum levels of albumin and recovery of the nutritional status. Thus, in AIP patients presenting with severe and persistent hypoproteinemia without apparent cause, clinicians need to consider Ménétrier's disease in the differential diagnosis. In this setting, endoscopic evaluation with histological examination of gastric biopsy material, including a full-thickness mucosal biopsy of involved mucosa, may be helpful in promptly establishing the diagnosis and allowing appropriate and timely therapy.


Resumo A doença de Ménétrier é uma condição extremamente rara, de etiologia desconhecida, caracterizada por hipertrofia da mucosa gástrica e gastropatia perdedora de proteína. Casos raros dessa patologia têm sido relatados em pacientes com doenças autoimunes. Até o momento, desconhecemos qualquer relato dessa doença associada à pancreatite autoimune (PAI). Descrevemos um caso de hipoproteinemia grave como indicador de doença de Ménétrier associada à PAI. O paciente foi tratado de forma satisfatória com octreotide e dieta hiperproteica, alcançando remissão sintomática, melhora significativa das concentrações de albumina e recuperação do estado nutricional. Portanto, em pacientes com PAI e hipoproteinemia grave e persistente, deve-se considerar a doença de Ménétrier como um diagnóstico diferencial. Nesses casos, a avaliação endoscópica com biópsia gástrica, incluindo biópsia de toda a espessura da mucosa, pode ser útil no estabelecimento do diagnóstico e do pronto início da terapêutica.


Subject(s)
Humans , Male , Pancreatitis/complications , Autoimmune Diseases/complications , Gastritis, Hypertrophic/complications , Hypoproteinemia/etiology , Pancreatitis/pathology , Pancreatitis/blood , Autoimmune Diseases/pathology , Autoimmune Diseases/blood , Biopsy , Severity of Illness Index , Endoscopy, Gastrointestinal , Gastric Mucosa/pathology , Gastritis, Hypertrophic/pathology , Gastritis, Hypertrophic/blood , Hypoproteinemia/pathology , Middle Aged
9.
Hum Mol Genet ; 26(1): 33-43, 2017 01 01.
Article in English | MEDLINE | ID: mdl-28013292

ABSTRACT

We performed whole exome sequencing in individuals from a family with autosomal dominant gastropathy resembling Ménétrier disease, a premalignant gastric disorder with epithelial hyperplasia and enhanced EGFR signalling. Ménétrier disease is believed to be an acquired disorder, but its aetiology is unknown. In affected members, we found a missense p.V742G variant in MIB2, a gene regulating NOTCH signalling that has not been previously linked to human diseases. The variant segregated with the disease in the pedigree, affected a highly conserved amino acid residue, and was predicted to be deleterious although it was found with a low frequency in control individuals. The purified protein carrying the p.V742G variant showed reduced ubiquitination activity in vitro and white blood cells from affected individuals exhibited significant reductions of HES1 and NOTCH3 expression reflecting alteration of NOTCH signalling. Because mutations of MIB1, the homolog of MIB2, have been found in patients with left ventricle non-compaction (LVNC), we investigated members of our family with Ménétrier-like disease for this cardiac abnormality. Asymptomatic left ventricular hypertrabeculation, the mildest end of the LVNC spectrum, was detected in two members carrying the MIB2 variant. Finally, we identified an additional MIB2 variant (p.V984L) affecting protein stability in an unrelated isolated case with LVNC. Expression of both MIB2 variants affected NOTCH signalling, proliferation and apoptosis in primary rat cardiomyocytes.In conclusion, we report the first example of left ventricular hypertrabeculation/LVNC with germline MIB2 variants resulting in altered NOTCH signalling that might be associated with a gastropathy clinically overlapping with Ménétrier disease.


Subject(s)
Cardiomyopathies/pathology , Gastritis, Hypertrophic/pathology , Mutation, Missense/genetics , Receptors, Notch/metabolism , Stomach Diseases/pathology , Ubiquitin-Protein Ligases/genetics , Ventricular Dysfunction, Left/pathology , Animals , Animals, Newborn , Cardiomyopathies/etiology , Cardiomyopathies/metabolism , Case-Control Studies , Cells, Cultured , Exome/genetics , Female , Gastritis, Hypertrophic/etiology , Gastritis, Hypertrophic/metabolism , Gene Expression Regulation , Humans , Male , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , Pedigree , Phenotype , Rats , Receptors, Notch/genetics , Signal Transduction , Stomach Diseases/etiology , Stomach Diseases/metabolism , Ubiquitin-Protein Ligases/metabolism , Ubiquitination , Ventricular Dysfunction, Left/etiology , Ventricular Dysfunction, Left/metabolism
12.
Nihon Shokakibyo Gakkai Zasshi ; 113(6): 975-82, 2016.
Article in Japanese | MEDLINE | ID: mdl-27264429

ABSTRACT

A 54-year-old man presented to our department with abdominal discomfort and anorexia and was diagnosed as having Ménétrier's disease (MD) with hilar cholangiocarcinoma. Based on his clinical examination, there was no evidence of Helicobacter pylori or cytomegalovirus (CMV) infection. Although we administered proton pump inhibitor and high-calorie enteral nutrition, hypoproteinemia did not improve, and the refractory protein-losing enteropathy persisted. However, interestingly, MD improved immediately after resection of the hilar cholangiocarcinoma. Generally, the etiology of MD is unknown, but H. pylori and CMV infections have been implicated. To our knowledge, there has been no previous report indicating that a malignant tumor could be involved in the etiology of MD. Thus, we report an extremely rare case of MD which is seemingly caused by malignancy.


Subject(s)
Bile Duct Neoplasms/complications , Gastritis, Hypertrophic/etiology , Klatskin Tumor/complications , Bile Duct Neoplasms/diagnostic imaging , Bile Duct Neoplasms/therapy , Biopsy , Gastritis, Hypertrophic/diagnostic imaging , Gastritis, Hypertrophic/pathology , Humans , Klatskin Tumor/diagnostic imaging , Klatskin Tumor/therapy , Male , Middle Aged , Treatment Outcome
16.
Nat Cell Biol ; 17(8): 984-93, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26192439

ABSTRACT

Successful pluripotent stem cell differentiation methods have been developed for several endoderm-derived cells, including hepatocytes, ß-cells and intestinal cells. However, stomach lineage commitment from pluripotent stem cells has remained a challenge, and only antrum specification has been demonstrated. We established a method for stomach differentiation from embryonic stem cells by inducing mesenchymal Barx1, an essential gene for in vivo stomach specification from gut endoderm. Barx1-inducing culture conditions generated stomach primordium-like spheroids, which differentiated into mature stomach tissue cells in both the corpus and antrum by three-dimensional culture. This embryonic stem cell-derived stomach tissue (e-ST) shared a similar gene expression profile with adult stomach, and secreted pepsinogen as well as gastric acid. Furthermore, TGFA overexpression in e-ST caused hypertrophic mucus and gastric anacidity, which mimicked Ménétrier disease in vitro. Thus, in vitro stomach tissue derived from pluripotent stem cells mimics in vivo development and can be used for stomach disease models.


Subject(s)
Cell Differentiation , Embryonic Stem Cells/physiology , Regenerative Medicine/methods , Stomach/physiology , Tissue Engineering/methods , Animals , Cell Differentiation/drug effects , Cell Lineage , Embryonic Stem Cells/drug effects , Embryonic Stem Cells/metabolism , Gastric Acid/metabolism , Gastric Mucosa/metabolism , Gastritis, Hypertrophic/genetics , Gastritis, Hypertrophic/metabolism , Gastritis, Hypertrophic/pathology , Gene Expression Profiling , Gene Expression Regulation, Developmental , Hedgehog Proteins/metabolism , Histamine/pharmacology , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Mice , Mice, Inbred ICR , Organogenesis , Pepsinogen A/metabolism , Phenotype , Spheroids, Cellular , Stomach/cytology , Stomach/drug effects , Time Factors , Transcription Factors/genetics , Transcription Factors/metabolism , Transfection , Transforming Growth Factor alpha/genetics , Transforming Growth Factor alpha/metabolism
17.
Mutagenesis ; 30(4): 537-44, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25805024

ABSTRACT

Epidemiological studies have demonstrated a close association between infection with Helicobacter pylori (H.pylori) and the development of gastric carcinoma. Chronic H.pylori infection increases the frequency of mutation in gastric epithelial cells. However, the mechanism by which infection of H.pylori leads to mutation in gastric epithelial cells is unclear. We suspected that components in H.pylori may be related to the mutagenic response associated with DNA alkylation, and could be detected with the Ames test using a more sensitive strain for alkylating agents. Our investigation revealed that an extract of H.pylori was mutagenic in the Ames test with Salmonella typhimurium YG7108, which is deficient in the DNA repair of O(6)-methylguanine. The extract of H.pylori may contain methylating or alkylating agents, which might induce O (6)-alkylguanine in DNA. Mutagenicity of the alkylating agents N-methyl-N-nitrosourea (MNU) and N-methyl-N'-nitro-N-nitrosoguanidine in the Ames test with S.typhimurium TA1535 was enhanced significantly in the presence of the extract of H.pylori. The tested extracts of H.pylori resulted in a significant induction of micronuclei in human-derived lymphoblastoid cells. Heat instability and dialysis resistance of the extracts of H.pylori suggest that the mutagenic component in the extracts of H.pylori is a heat-unstable large molecule or a heat-labile small molecule strongly attached or adsorbed to a large molecule. Proteins in the extracts of H.pylori were subsequently fractionated using ammonium sulphate precipitation. However, all fractions expressed enhancing effects toward MNU mutagenicity. These results suggest the mutagenic component is a small molecule that is absorbed into proteins in the extract of H.pylori, which resist dialysis. Continuous and chronic exposure of gastric epithelial cells to the alkylative mutagenic component from H.pylori chronically infected in the stomach might be a causal factor in the gastric carcinogenesis associated with H.pylori.


Subject(s)
Cell Extracts/pharmacology , DNA Damage/drug effects , Helicobacter Infections/microbiology , Helicobacter pylori/pathogenicity , Lymphocytes/drug effects , Mutagens/pharmacology , Anemia, Iron-Deficiency/microbiology , Anemia, Iron-Deficiency/pathology , Cells, Cultured , DNA Repair/drug effects , Gastritis, Hypertrophic/microbiology , Gastritis, Hypertrophic/pathology , Helicobacter Infections/pathology , Helicobacter pylori/isolation & purification , Humans , Lymphocytes/metabolism , Micronucleus Tests/methods , Mutagenicity Tests/methods , Mutation/genetics , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Stomach Ulcer/microbiology , Stomach Ulcer/pathology
19.
J Coll Physicians Surg Pak ; 24 Suppl 3: S183-5, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25518766

ABSTRACT

Ménétrier's Disease (MD) is a rare acquired hypertrophic gastropathy characterized by giant hypertrophic rugal folds, hypochlorhydria, and hypoproteinemia. The definitive etiology of MD is controversial, although infection with Helicobacter pylori (H. pylori) has been implicated in adults. It presents as a constellation of symptoms including epigastric pain, fatigue, vomiting, weight loss, anorexia, and edema. None of these signs and symptoms is specific for the disease. The gastrointestinal symptoms and the degree of hypoalbuminemia can be profound, the latter resulting from the leakage of protein from the gastric lining. The disease is more common in males. Herein, we report a case of a young woman presenting with the chief complaint of peripheral edema with minimal gastrointestinal symptoms, which was diagnosed as MD on endoscopic evaluation and histopathological examination of gastric biopsy. A high index of suspicion is needed to correctly diagnose this condition for its optimal management.


Subject(s)
Gastric Mucosa/pathology , Gastritis, Hypertrophic/diagnosis , Polyps/pathology , Adult , Biopsy , Diagnosis, Differential , Endoscopy, Digestive System , Female , Gastritis, Hypertrophic/pathology , Gastritis, Hypertrophic/therapy , Humans , Polyps/diagnosis , Proton Pump Inhibitors/therapeutic use , Stomach Diseases/diagnosis
20.
Rev Chil Pediatr ; 85(1): 80-5, 2014 Feb.
Article in Spanish | MEDLINE | ID: mdl-25079188

ABSTRACT

INTRODUCTION: Ménétrier disease is a rare disorder characterized by gastric foveolar hyperplasia associated with secondary protein loss. In children, this condition is presented as an edematous syndrome without renal or hepatic impairment and differs from the adult form by the constant presence of edema and spontaneous remission. It has been related to infections in most published cases, especially to Cytomegalovirus (CMV) and Helicobacter pylori (H. pylori). OBJECTIVE: To present a pediatric case of Ménétrier disease and endoscopic imaging obtained during the evolution of the patient. CASE REPORT: A five year old preschooler who presented a generalized edema, abdominal pain and malaise. After ruling out renal and hepatic pathologies, an upper endoscopy revealed a severe compromise of the gastric mucosa. Urease test for H. pylori and IgG test for CMV resulted positive. Albumin and H2 receptor antagonists were administered. The evolution was favorable and the patient was discharged after 14 days; 8 month follow-up endoscopy showed no abnormalities. CONCLUSION: The medical profile and endoscopy are enough evidence to suggest the diagnosis of hypertrophic protein-losing gastropathy. Further studies need to be developed that include a considerable number of patients to assess their association with CMV or H. pylori infections, as these viruses are very common in our population.


Subject(s)
Cytomegalovirus Infections/diagnosis , Gastric Mucosa/pathology , Gastritis, Hypertrophic/diagnosis , Helicobacter Infections/diagnosis , Abdominal Pain/etiology , Albumins/administration & dosage , Child, Preschool , Edema/etiology , Female , Follow-Up Studies , Gastritis, Hypertrophic/drug therapy , Gastritis, Hypertrophic/pathology , Gastroscopy/methods , Helicobacter pylori/isolation & purification , Histamine H2 Antagonists/therapeutic use , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...